adenosine monophosphate has been researched along with Acute Liver Injury, Drug-Induced in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (33.33) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (14.29) | 24.3611 |
2020's | 10 (47.62) | 2.80 |
Authors | Studies |
---|---|
Bates, C; Garnick, L; Maier, A; Massarsky, A; Monnot, AD; Spencer, P; Sura, P | 1 |
Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R | 1 |
Bosma, LBE; Burger, DM; Leegwater, E; Ottens, TH; Strik, A; van Nieuwkoop, C; Wilms, EB | 1 |
Durrieu, G; Montastruc, F; Thuriot, S | 1 |
Andini, R; Bertolino, L; Corcione, A; De Rosa, R; Durante-Mangoni, E; Florio, LL; Galdo, M; Mele, F; Zampino, R | 1 |
Martín Mateos, RM; Téllez, L | 1 |
Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A | 1 |
Morris, AM; Wu, PE | 2 |
Bahçecíoğlu, ÖF; Durmuş, M; Gök, S | 1 |
Ding, B; Hou, Y; Li, J; Liu, Y; Long, M; Wang, L; Wu, G; Yang, Z; Yi, D | 1 |
Hua, Z; Wang, S; Wang, T; Wang, Y; Wang, Z; Xia, L; Yang, P; Zhan, Y; Zhang, J; Zhou, M | 1 |
Kong, Y; Sun, Q; Xu, X; Yang, X; Zhan, Y; Zhang, J | 1 |
GOEGGEL, KH; JAROSCHKA, R; OPPERMANN, F | 1 |
Uchida, K | 1 |
Katayama, T; Kimura, T; Miura, S; Shimamura, M | 1 |
Chagoya de Sánchez, V; Hernández-Muñoz, R | 1 |
Awadallah, R; El-Dessoukey, EA; Mikhail, TH | 1 |
Blumenthal, B | 1 |
Bode, JC | 1 |
Laberge, C; Lescault, A | 1 |
2 review(s) available for adenosine monophosphate and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Dose and exposure route analyses inform relationships between liver steatosis and 2-amino-2-methyl-1-propanol: Implications for hazard characterization.
Topics: Adenosine Monophosphate; Animals; Chemical and Drug Induced Liver Injury; Choline; Fatty Liver; Humans | 2022 |
COVID-19 and liver disease: An update.
Topics: Adenosine Monophosphate; Age Factors; Alanine; Antiviral Agents; Betacoronavirus; Bile Ducts; Chemical and Drug Induced Liver Injury; Chronic Disease; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Gastroenterology; Health Resources; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Liver; Liver Diseases; Liver Function Tests; Liver Transplantation; Obesity; Pandemics; Pneumonia, Viral; Resource Allocation; Risk Factors; SARS-CoV-2 | 2020 |
19 other study(ies) available for adenosine monophosphate and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes | 2020 |
Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; Chemical and Drug Induced Liver Injury; COVID-19 Drug Treatment; Humans; Male; SARS-CoV-2 | 2021 |
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Europe; Female; Humans; Incidence; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States | 2020 |
Liver injury in remdesivir-treated COVID-19 patients.
Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Italy; Liver Function Tests; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting | 2020 |
Remdesivir for patients with COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chemical and Drug Induced Liver Injury; COVID-19 Drug Treatment; Critical Care; Drug Hypersensitivity; Humans; SARS-CoV-2; Treatment Outcome | 2021 |
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?
Topics: Adenosine Monophosphate; Alanine; ATP Binding Cassette Transporter, Subfamily B; Chemical and Drug Induced Liver Injury; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; SARS-CoV-2 | 2021 |
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chemical and Drug Induced Liver Injury; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Hypersensitivity; Humans; SARS-CoV-2; Treatment Outcome | 2021 |
Dietary N-acetylcysteine supplementation alleviates liver injury in lipopolysaccharide-challenged piglets.
Topics: Acetylcysteine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Cytokines; Dietary Supplements; Disease Models, Animal; Energy Metabolism; Female; HSP70 Heat-Shock Proteins; Inflammation Mediators; Lipopolysaccharides; Liver; NF-kappa B; Random Allocation; Swine | 2014 |
Adenosine 5'-monophosphate ameliorates D-galactosamine/lipopolysaccharide-induced liver injury through an adenosine receptor-independent mechanism in mice.
Topics: Adenosine Monophosphate; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Humans; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha | 2014 |
Adenosine 5'-monophosphate blocks acetaminophen toxicity by increasing ubiquitination-mediated ASK1 degradation.
Topics: Acetaminophen; Adenosine Monophosphate; Animals; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Liver; Male; MAP Kinase Kinase Kinase 5; Methylation; Mice, Inbred C57BL; Protective Agents; Proteolysis; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Time Factors; Ubiquitination | 2017 |
[STATIONARY CONCENTRATION OF ATP, ADP AND AMP IN NORMAL LIVERS AND LIVERS WITH LESIONS CAUSED BY CARBON TETRACHLORIDE POISONING IN MICE].
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Hepatitis; Hepatitis A; Mice; Research; Toxicology | 1964 |
[Alterations in hepatic high-energy metabolism in galactosamine-induced acute hepatic failure in rabbits].
Topics: Acute Disease; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Energy Metabolism; Galactosamine; Liver; Liver Diseases; Mitochondria, Liver; Rabbits | 1984 |
A histological study on hepatic changes induced by the administration of ATP, ADP and AMP.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Granuloma; Liver; Male; Rats; Sclerosis; Time Factors | 1980 |
In vivo correlation between liver and blood energy status as evidenced by chronic treatment of carbon tetrachloride and adenosine to rats.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Liver; Liver Diseases; Nucleotides; Phosphates; Rats; Rats, Wistar | 1994 |
Effect of AMP on serum minerals in carbon-tetrachloride hepatotoxicity.
Topics: Adenosine Monophosphate; Animals; Calcium; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Copper; Electrolytes; Female; Iron; Magnesium; Male; Potassium; Premedication; Rats; Sodium; Zinc | 1978 |
[The treatment of alcoholic delerium tremors and acute attacks of alcoholic toxic hepatitis].
Topics: Adenosine Monophosphate; Alcohol Withdrawal Delirium; Alcoholism; Chemical and Drug Induced Liver Injury; Chlormethiazole; Deanol; Drug Combinations; Humans; Methionine; Psychoses, Alcoholic; Vitamin B 12 | 1975 |
[Undesirable metabolic effects following the administration of higher doses of fructose and sorbitol].
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Fructose; Glucose; Hepatitis; Humans; Liver; Parenteral Nutrition; Rats; Sorbitol; Uric Acid | 1974 |
[Effects of methionine poisoning on energy metabolism in the guinea pig liver].
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Energy Metabolism; Glucose; Glycolysis; Guinea Pigs; Injections, Intraperitoneal; Liver; Male; Methionine; Mitochondria, Liver; Oxidative Phosphorylation; Oxygen Consumption; Poisoning; Time Factors | 1974 |